Lifelong yearly prostate specific antigen surveillance is not necessary for low risk prostate cancer treated with radical prostatectomy

Matthew K. Tollefson, Michael L. Blute, Laureano J. Rangel, R. Jeffrey Karnes, Igor Frank

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Lifelong yearly prostate specific antigen surveillance is not necessary for low risk prostate cancer treated with radical prostatectomy'. Together they form a unique fingerprint.

Medicine & Life Sciences